Vascular News and Research

RSS

Hotspur announces successful completion of GPSCath Catheter in peripheral angioplasty surgery

Hotspur Technologies, announced today that Dr. Greg Sampognaro, Interventional Cardiologist at P & S Surgical Hospital in Monroe, Louisiana, successfully completed the first use of the GPSCath Balloon Dilatation Catheter in an intervention to treat a blocked peripheral artery.

18 Jan 2011

Palomar Medical introduces Artisan Aesthetic System to provide laser skin resurfacing treatment

Palomar Medical Technologies, a leading researcher and developer of lasers and pulsed-light systems for aesthetic treatments, is pleased to announce that the Artisan Aesthetic System is now being shipped.

18 Jan 2011

EverFlex+ Self-Expanding Peripheral Stent System is now available in Europe

Covidien, a leading global provider of healthcare products, today announced availability of the EverFlex+™ Self-Expanding Peripheral Stent System in Europe.

18 Jan 2011

12-HETE enzyme inhibition can prevent ischemic retinopathy: Study

The inhibition or removal of an enzyme may prevent or treat ischemic retinopathy by stalling growth of unwanted vessels in the retina, Medical College of Georgia researchers say.

14 Jan 2011

FibroGen initiates FG-3019 open-label phase 2 study in idiopathic pulmonary fibrosis

FibroGen, Inc. today announced initiation of an open-label phase 2 study to evaluate the safety, tolerability, and efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), in individuals with idiopathic pulmonary fibrosis (IPF), a chronic, progressive, fatal lung disease for which there are no FDA-approved therapies.

13 Jan 2011

Pfizer initiates rolling submission of crizotinib NDA for ALK-positive advanced NSCLC

Pfizer Inc. announced today that it has initiated the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for crizotinib (PF-02341066), an oral first-in-class anaplastic lymphoma kinase (ALK) inhibitor for the treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors are ALK-positive. Pfizer expects to complete the submission in the first half of 2011.

13 Jan 2011

Study highlights important clinical implications of miR-503 in diabetes-associated vascular complications

New research has found one of the smallest entities in the human genome, micro-RNA, could increase the risk of limb amputation in diabetic patients who have poor blood flow.

13 Jan 2011

Winter weather tips for people with high blood pressure

It's sad but true. Celebrity groundhog Punxsutawney Phil of PA and his relatives accurately predict the end or extension of winter only 39 percent of the time according to the United States National Climate Center.

12 Jan 2011

Surge in cataract surgeries fuels intraocular lens market to almost $1.4 billion

According to two new reports by iData Research, the leading global authority in medical device and pharmaceutical market research, growth in the use of optical coherence tomography (OCT) for the detection of ocular conditions will drive the U.S. diagnostic ophthalmic market to over $650 million by 2017.

12 Jan 2011

Rice, BCM discovery addresses key roadblock to growing replacement tissues, organs

Researchers from Rice University and Baylor College of Medicine (BCM) have broken one of the major roadblocks on the path to growing transplantable tissue in the lab: They've found a way to grow the blood vessels and capillaries needed to keep tissues alive.

12 Jan 2011

Apixaban drug raises hope for DVT prevention in patients undergoing hip replacement surgery

A worldwide research consortium that includes the University of Oklahoma Health Sciences Center has proven that a new drug is more effective and easier to use than current medicines in the prevention of blood clots following hip replacement surgery.

12 Jan 2011

Vermillion receives USPTO patent for PAD biomarker

Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office has issued patent number 7,867,719 entitled "Beta-2 microglobulin as a biomarker for peripheral artery disease" to the Company.

12 Jan 2011

BPH, hair loss prevention drugs may produce adverse side effects in men

Researchers from Boston University School of Medicine, in collaboration with colleagues at Lahey Clinic and from Denmark and Germany, have found that 5a-reductase inhibitors, while improving urinary symptoms in patients with benign prostatic hyperplasia and possible hair loss prevention, produces significant adverse effects in some individuals including loss of libido, erectile dysfunction, ejaculatory dysfunction and potential depression.

12 Jan 2011

AccessClosure launches Mynx Cadence Vascular Closure Device

AccessClosure, the U.S. market leader in extravascular closure devices, announced today the launch of its next generation product, the Mynx Cadence Vascular Closure Device.

11 Jan 2011

Haiti teen to undergo open-heart surgery at Montefiore

Mahalia Desruisseaux, M.D., assistant professor of pathology and of medicine at Albert Einstein College of Medicine of Yeshiva University who had traveled to Haiti to assist in the relief effort, identified a serious heart condition. Now, one year later, Ms. Ajuste will undergo open-heart surgery at Montefiore, The University Hospital and Academic Medical Center for Einstein, to correct the defect.

11 Jan 2011

First commercial deployment of Hotspur GPSCath Balloon Dilatation Catheter

Hotspur Technologies, Inc. announced today that Dr. Bruce Lin, M.D., and Dr. Stephen Liu, M.D., Interventional Radiologists at Lifelink Interventional Center in Modesto, California, performed the first commercial deployment of the company's GPSCath™ Balloon Dilatation Catheter.

11 Jan 2011

Novel scoring system identifies PTEN genetic mutation

Researchers have discovered a method for more precise identification of individuals who should undergo testing for genetic mutations of the tumor suppressor gene PTEN, which associates with a variety of conditions including several types of cancers. The research has created a diagnostic scoring system that improves on established criteria.

11 Jan 2011

Baylor Hamilton offers Arctic Front Cardiac CryoAblation Catheter system treatment for paroxysmal atrial fibrillation

Physicians at Baylor Jack and Jane Hamilton Heart and Vascular Hospital are the first in North Texas to offer the Arctic Front® Cardiac CryoAblation Catheter system, the first and only cryoballoon in the United States indicated to treat drug refractory recurrent symptomatic paroxysmal atrial fibrillation (PAF), a serious heart rhythm disorder that affects millions of Americans.

11 Jan 2011

Study: Protein that plays a key role in some antioxidant therapies can promote atherosclerosis

UCLA researchers have found that a protein that plays an important role in some antioxidant therapies may not be as effective due to additional mechanisms that cause it to promote atherosclerosis, or clogging of the arteries.

11 Jan 2011

Teleflex announces acquisition of VasoNova

Teleflex Incorporated, a leading global provider of medical technology products, today announced it has acquired privately-held VasoNova Inc. in a transaction valued at up to $55 million.

10 Jan 2011

Vascular News and Research

Hotspur announces successful completion of GPSCath Catheter in peripheral angioplasty surgery

Palomar Medical introduces Artisan Aesthetic System to provide laser skin resurfacing treatment

EverFlex+ Self-Expanding Peripheral Stent System is now available in Europe

12-HETE enzyme inhibition can prevent ischemic retinopathy: Study

FibroGen initiates FG-3019 open-label phase 2 study in idiopathic pulmonary fibrosis

Pfizer initiates rolling submission of crizotinib NDA for ALK-positive advanced NSCLC

Study highlights important clinical implications of miR-503 in diabetes-associated vascular complications

Winter weather tips for people with high blood pressure

Surge in cataract surgeries fuels intraocular lens market to almost $1.4 billion

Rice, BCM discovery addresses key roadblock to growing replacement tissues, organs

Apixaban drug raises hope for DVT prevention in patients undergoing hip replacement surgery

Vermillion receives USPTO patent for PAD biomarker

BPH, hair loss prevention drugs may produce adverse side effects in men

AccessClosure launches Mynx Cadence Vascular Closure Device

Haiti teen to undergo open-heart surgery at Montefiore

First commercial deployment of Hotspur GPSCath Balloon Dilatation Catheter

Novel scoring system identifies PTEN genetic mutation

Baylor Hamilton offers Arctic Front Cardiac CryoAblation Catheter system treatment for paroxysmal atrial fibrillation

Study: Protein that plays a key role in some antioxidant therapies can promote atherosclerosis

Teleflex announces acquisition of VasoNova

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News